Adhering to the 3Rs principles (Replacement, Reduction, and Refinement), we actively promote the development of alternative non-animal experimental technologies while deeply integrating the core concepts of regenerative medicine and anti-aging into our R&D system.

We have established multiple internationally leading technology platforms:

• Plant Synthetic Biology Platform: Delivers efficient and safe plant-derived biomaterials, providing innovative solutions for cell therapy and precision medicine.

• Organoid Culture Technology Platform: Enables advanced disease modeling and drug discovery, accelerating the translational application of cell-based therapies.

• Regenerative Medical Hydrogel Development Platform: Drives breakthrough applications in tissue repair, anti-aging, and skin regeneration.

These technology platforms not only significantly reduce reliance on animal experimentation in traditional R&D, but also demonstrate strong potential in cell therapy, anti-aging, and the silver economy—providing robust technological support for global regenerative medicine and tissue engineering.

COOP is committed to fostering a corporate culture grounded in 3R ─ Revolutionary, Respect, and Responsibility.